ALEXANDRA CLARK: Open Payments
NPI 1043829641 · ROCHESTER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$765 in 50 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $31 · 2025 $765
Food & beverage: $745Education: $19
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $241 |
| Novartis Pharmaceuticals Corporation | 23 | $204 |
| GENZYME CORPORATION | 5 | $115 |
| Galderma Laboratories, L.P. | 3 | $53 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $45 |
| Janssen Biotech, Inc. | 1 | $30 |
| UCB, Inc. | 1 | $30 |
| Amgen Inc. | 1 | $25 |
| Incyte Corporation | 1 | $21 |
Products named: SKYRIZI, COSENTYX, DUPIXENT, NEMLUVIO, ILUMYA, TREMFYA, Bimzelx, OTEZLA.
Industry payments across NY — which companies pay providers there.
